Kidney360

Transplant Nephrologists' Preferences for Clinical Decision Support for APOL1 Genetic Testing: A Focus Group Study

Kidney360

Show Notes

Opportunities exist for clinical decision support (CDS) to help transplant nephrologists counsel living donors receiving APOL1 genetic test results. A new Kidney360 study provides insights from transplant nephrologists on how this CDS should be developed.

More from Kidney360

Jul 30, 2026

In 11,409 adults with CKD and no prior heart failure, three standard ECG features independently predicted new-onset HF hospitalization. The findings support routine ECG as a low-cost adjunct to existing HF risk assessment in CKD.

May 28, 2026

Sickle cell disease causes accelerated kidney function decline, yet proven GFR-preserving therapies remain elusive. In this study of adults with sickle cell disease, RASi use was not associated with a significant difference in the rate of eGFR decline.

Apr 30, 2026

This podcast discusses a post hoc analysis of the STOP-ACEi trial, examining whether baseline loop diuretic use modifies the effect of Renin–Angiotensin System Inhibitors in advanced CKD.

Feb 26, 2026

This episode highlights data from a qualitative substudy of the AV Access trial, a randomized controlled trial studying outcomes of older adults who are receiving hemodialysis with a central venous catheter.

Oct 30, 2025

Dialysis in infants with ESKD is often associated with multiple comorbidities and the need for more intensified dialysis regimens. This study found that infant ESKD is associated with significant health care utilization.

See all episodes →